Atelocollagen Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 9.43 Billion |
| Market Size (2029) | USD 12.53 Billion |
| CAGR (2024 - 2029) | 5.85 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Atelocollagen Market Analysis
The Atelocollagen Market size is estimated at USD 9.43 billion in 2024, and is expected to reach USD 12.53 billion by 2029, growing at a CAGR of 5.85% during the forecast period (2024-2029).
The atelocollagen market is experiencing significant growth due to its wide range of pharmaceuticals, medical devices, and cosmetics applications. Atelocollagen is a water-soluble form of collagen. It reduces immunogenicity and offers enhanced biocompatibility, making it highly desirable for cell culture, drug delivery systems, and wound healing. Atelocollagen can be engineered into various physical shapes such as films, string-like configurations, sponge-like structures, gels, and powders.
The demand for tissue engineering and regenerative medicines has increased in recent years owing to the growing prevalence of chronic diseases and organ failure. Atelocollagen plays a significant role in cell therapy, tissue engineering, and regenerative medicines. It is used as a scaffold to support the growth and repair of organs and tissues. The use of atelocollagen-based biomaterials in tissue engineering applications has been growing rapidly. Atelocollagen possesses a significant advantage in being biocompatible, biodegradable, readily available, and highly versatile. These properties of atelocollagen lead to drive its demand globally.
Additionally, the growing demand for atelocollagen in the pharmaceutical industry influences market growth. Atelocollagen is vital in producing membranes and sponges for drug delivery systems. A recent example is cancer therapeutics, where atelocollagen-mediated delivery of anticancer siRNAs is attracting interest.
Furthermore, atelocollagen is used as a moisturizing agent in various skin care products, which include facial lotions/creams, anti-aging serums, face masks, eye creams, sunscreens, and lip balms. Atelocollagen helps to keep the skin hydrated, smooth, and radiant. For example, COLWAY Atelocollagen, a premium anti-aging product manufactured by COLWAY, targets the root cause of skin aging. Such anti-aging benefits of atelocollagen stimulate market growth over the forecast period.
Moreover, increasing collaborations and partnerships among key players to launch innovative skincare products will influence market growth. For instance, in February 2024, Promed Bioscience, a manufacturer of collagen biomaterials, announced its strategic collaboration with Maintrix, a prominent cosmeceuticals manufacturer. The partnership aims to expand Promed Bioscience's skin care products portfolio, including CollX3, a water-soluble triple atelocollagen complex. The partnership aims to bring innovative medical skincare solutions to consumers.
However, strict regulatory guidelines for developing, approving, and marketing atelocollagen products might hamper the market growth. Additionally, the high cost of manufacturing atelocollagen and the availability of alternative biomaterials may threaten the market share.
Atelocollagen Market Trends
Bovine Collagen Segment is Expected to Witness Significant Growth During the Forecast Period
- Bovine collagen is a naturally occurring protein derived from cows. The high availability of cattle and reasonable prices of bovine-based products are boosting segmental growth. The demand for bovine collagen is increasing for biomedical applications to treat various medical conditions such as improved skin health, arthritis, and osteoporosis.
- According to the data published by the Institute for Health Metrics and Evaluation in August 2023, osteoarthritis affected 15.0% of the global population aged 30 years and above. Furthermore, it is estimated that around 1.0 billion people will suffer from osteoarthritis by 2050. Additionally, as per the article published in the American Academy of Family Physicians in March 2023, osteoporosis affects 10.2% of adults aged 50 years and above and is expected to reach 13.6% by 2030. Thus, the high prevalence of osteoporosis boosts the demand for bovine collagen as it helps to improve bone mineral density, which is further anticipated to drive segmental growth.
- Moreover, the rising research and development activities in regenerative medicines and wound healing and the growing demand for orthopedic and dental surgeries for reconstruction are influencing segmental growth. As per the data published by the Arthritis Foundation, hip replacement surgeries are projected to reach 635.0 million, i.e., a 171.0% increase, while knee replacement surgeries are anticipated to reach 1.28 million, a 189.0% increase by 2030. Atelocollagen sponges are used in dental surgeries owing to their excellent biocompatibility, weak antigenicity, and biodegradability.
- Therefore, owing to factors such as the high prevalence of osteoporosis, growing research and development activities in regenerative medicines, and growing demand for dental surgeries, the bovine collagen segment is projected to grow during the forecast period.
North America is Expected to Dominate the Atelocollagen Market
- North America accounted for the highest market share due to the growing demand for tissue engineering, the increasing incidence of bone-related disorders, the rising geriatric population, better healthcare infrastructure, and robust research and development activities. For instance, according to data published in the University of British Columbia journal, in February 2021, around 2.2 million people in Canada had osteoporosis. In addition, according to the data published by the International Osteoporosis Foundation in March 2023, in Mexico, the prevalence of musculoskeletal disorders among the aged population above 60 years and older was 36.4%. The aging population is highly prone to musculoskeletal disorders, which is another critical factor in the growth of the market. Thus, the demand for atelocollagen is projected to grow soon as it helps to increase bone density in the aged population.
- Moreover, growing applications in the cosmetic industry due to its healthy aging benefits on hair, skin, and nail beauty have driven the demand for atelocollagen in the region owing to a growing inclination toward nutritional products.
- The leading vendors in the North American market are concentrating on new product launches for 2D and 3D cell culture, drug delivery, labware coating applications, bioprinting, and as a scaffold for a myriad of tissue engineering modalities. For instance, in January 2023, Essent Biologics, a biotechnology company, launched its Human Native Tissue-Derived Type I atelocollagen for the cell and tissue engineering industry. Atelocollagen provides a high-quality standard for customers to use as a raw material in their research and manufacturing procedures. Such high-quality applications of atelocollagen help boost market growth in the region.
- Furthermore, the growing number of campaigns highlighting the use of collagen among all ages contributes significantly to the North American market’s growth. For instance, in January 2024, Vital Proteins LLC launched a campaign named "For Everybody with a Body," highlighting collagen's benefits for adults of all ages. Such initiatives are projected to drive the adoption of atelocollagen in the region.
Atelocollagen Industry Overview
The atelocollagen market is highly competitive, with a significant number of players. Prominent players in the atelocollagen market are increasing their investments in R&D activities to bring innovative products into the market. The players in the market account for significant market share and are well known, including KOKEN CO. LTD, MD Bioproducts, COLWAY, Advanced BioMatrix (BICO), DSM, Nitta Gelatin Inc., Promed Bioscience, Zhejiang Chumsun Biological Products Co. Ltd, VitaCare-Biotechnology Limited, DALIM TISSEN Co. Ltd, and PELOBIOTECH GmbH.
Atelocollagen Market Leaders
-
KOKEN CO., LTD.
-
MD Bioproducts
-
COLWAY
-
Advanced BioMatrix (BICO)
-
DSM
*Disclaimer: Major Players sorted in no particular order
Atelocollagen Market News
- February 2023: Ilex Life Sciences became a Promed Bioscience collagen-based biomaterials distributor in the United States and Canada.
- February 2022: Nestlé Health Science completed the acquisition of Vital Proteins LLC, a collagen provider in the United States and a prominent lifestyle and wellness platform offering beverages, food, and supplements products.
Atelocollagen Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumption and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Growing Demand for Tissue Engineering and Regenerative Medicine
- 4.2.2 Increasing Collaborations and Partnerships for Product Development
- 4.2.3 Growing Inclination Toward Aesthetic Procedures
-
4.3 Market Restraints
- 4.3.1 High Cost of Manufacturing Atelocollagen and Availability of Alternative Biomaterials
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD)
-
5.1 By Source
- 5.1.1 Bovine Collagen
- 5.1.2 Porcine Collagen
- 5.1.3 Other Sources
-
5.2 By Application
- 5.2.1 Tissue Engineering
- 5.2.2 Wound Healing
- 5.2.3 Cosmetics
- 5.2.4 Other Applications
-
5.3 By End User
- 5.3.1 Pharmaceutical and Biotechnology Companies
- 5.3.2 Research Institutes and Laboratories
- 5.3.3 Other End Users
-
5.4 By Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East and Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East and Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 KOKEN CO. LTD
- 6.1.2 MD Bioproducts
- 6.1.3 COLWAY
- 6.1.4 Advanced BioMatrix (BICO)
- 6.1.5 DSM
- 6.1.6 Nitta Gelatin Inc.
- 6.1.7 Promed Bioscience
- 6.1.8 Zhejiang Chumsun Biological Products Co. Ltd
- 6.1.9 VitaCare-Biotechnology Limited
- 6.1.10 DALIM TISSEN Co. Ltd
- 6.1.11 PELOBIOTECH GmbH
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityAtelocollagen Industry Segmentation
As per the scope of the report, atelocollagen is a type of collagen that undergoes a specific process of removing the telopeptides from the collagen molecule, resulting in reduced antigenicity. It has a wide range of applications in tissue culture research, clinical medicine, and cosmetics.
The atelocollagen market is segmented by source, application, end user, and geography. By source, the market is segmented into bovine collagen, porcine collagen, and other sources. The other sources segment includes mouse collagen and rat collagen. By application, the market is segmented into tissue engineering, wound healing, cosmetics, and other applications. By end user, the market is segmented into pharmaceutical and biotechnology companies, research institutes and laboratories, and other end users. The report also covers the market size and forecasts for the atelocollagen market in 17 countries across major regions. For each segment, the market sizing and forecasts were made on the basis of value (USD).
| By Source | Bovine Collagen | |
| Porcine Collagen | ||
| Other Sources | ||
| By Application | Tissue Engineering | |
| Wound Healing | ||
| Cosmetics | ||
| Other Applications | ||
| By End User | Pharmaceutical and Biotechnology Companies | |
| Research Institutes and Laboratories | ||
| Other End Users | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| By Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| By Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| By Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| By Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Atelocollagen Market Research FAQs
How big is the Atelocollagen Market?
The Atelocollagen Market size is expected to reach USD 9.43 billion in 2024 and grow at a CAGR of 5.85% to reach USD 12.53 billion by 2029.
What is the current Atelocollagen Market size?
In 2024, the Atelocollagen Market size is expected to reach USD 9.43 billion.
Who are the key players in Atelocollagen Market?
KOKEN CO., LTD., MD Bioproducts, COLWAY, Advanced BioMatrix (BICO) and DSM are the major companies operating in the Atelocollagen Market.
Which is the fastest growing region in Atelocollagen Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Atelocollagen Market?
In 2024, the North America accounts for the largest market share in Atelocollagen Market.
What years does this Atelocollagen Market cover, and what was the market size in 2023?
In 2023, the Atelocollagen Market size was estimated at USD 8.88 billion. The report covers the Atelocollagen Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Atelocollagen Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Atelocollagen Industry Report
Statistics for the 2024 Atelocollagen market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Atelocollagen analysis includes a market forecast outlook for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
